AT7L3 Polyclonal Antibody

The SGF11-type zinc finger mediates the interaction with USP22 and ENY2.,Component of the transcription regulatory histone acetylation (HAT) complex SAGA, a multiprotein complex that activates transcription by remodeling chromatin and mediating histone acetylation and deubiquitination. Within the SAGA complex, participates to a subcomplex that specifically deubiquitinates both histones H2A and H2B. The SAGA complex is recruited to specific gene promoters by activators such as MYC, where it is required for transcription. Required for nuclear receptor-mediated transactivation. Within the complex, it is required to recruit USP22 and ENY2 into the SAGA complex.,Belongs to the SGF11 family.,Contains 1 SCA7 domain.,Contains 1 SGF11-type zinc finger.,subunit:Component of some SAGA transcription coactivator-HAT complex, at least composed of ATXN7, ATXN7L3, ENY2, GCN5L2, SUPT3H, TAF10, TRRAP and USP22. Within the SAGA complex, ATXN7L3, ENY2 and USP22 form a subcomplex required for histone deubiquitinylation. Interacts directly with ENY2 and USP22.,

The AT7L3 Polyclonal Antibody is a highly specific and sensitive immunological tool designed for the detection and analysis of AT7L3 protein expression in various biological samples. This antibody is produced by immunizing rabbits with a synthetic peptide corresponding to a unique epitope of the AT7L3 protein.

The AT7L3 Polyclonal Antibody exhibits exceptional affinity and selectivity towards the target protein, ensuring accurate and reliable results in a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence. It has been rigorously validated for its specificity and sensitivity, guaranteeing minimal cross-reactivity with other proteins.

With its superior performance characteristics, the AT7L3 Polyclonal Antibody enables researchers to investigate the role and function of AT7L3 protein in various biological processes and disease states. Its robust and consistent performance ensures reproducible and interpretable data, facilitating meaningful scientific discoveries.

The AT7L3 Polyclonal Antibody is supplied as a liquid formulation, ready for immediate use. It is provided in a convenient size and quantity, ensuring cost-effectiveness and minimizing wastage. Each batch of the antibody undergoes stringent quality control measures to ensure batch-to-batch consistency and reliability.

Choose the AT7L3 Polyclonal Antibody for its exceptional specificity, sensitivity, and reliability, and unlock new insights into the biology and pathology of AT7L3 protein.